TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CVS

CVS Health Corp

Healthcare · Healthcare Plans

89.10$ +4.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

CVS Health Corp (CVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 253,768 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CVS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
251,306 249,728 249,743 252,481 252,427 253,215 255,585 258,343 255,327 261,064 252,974 253,768
70,143 67,858 67,473 69,952 67,343 68,645 73,191 75,649 77,109 74,714 74,817 75,346
13,043 8,196 9,801 12,507 6,875 8,586 10,076 11,787 9,155 8,512 9,542 11,329
16,188 11,455 13,089 16,262 9,680 10,993 12,654 14,216 11,289 10,657 11,802 13,958
32,927 35,227 32,217 32,385 36,179 36,469 39,625 40,651 43,857 39,779 40,992 40,309
17,954 18,025 16,346 16,068 17,649 18,107 17,385 17,447 18,962 19,246 17,770 17,622
30,586 – – – 28,959 28,937 28,560 28,337 28,109 28,056 – –
91,261 91,272 91,272 91,272 91,272 91,272 91,203 91,203 85,478 85,478 85,478 85,478
29,624 29,234 28,770 28,311 27,817 27,323 26,570 26,224 25,984 25,508 25,070 24,644
176,796 173,092 175,593 177,370 177,321 177,485 178,475 180,792 182,217 185,682 175,337 173,869
81,553 79,189 83,319 81,386 84,627 84,609 88,961 94,162 92,695 88,692 86,406 87,041
3,873 4,713 8,356 5,642 7,622 7,494 7,579 11,106 7,237 5,805 4,484 3,872
14,874 14,897 13,717 14,416 15,713 15,892 16,534 17,258 60,947 59,384 16,922 17,167
59,782 58,638 57,694 62,643 59,824 60,527 59,040 57,290 60,508 60,502 60,531 59,452
74,337 76,461 73,968 74,930 74,944 75,560 76,929 77,379 72,928 75,214 77,456 79,702
60,343 61,604 61,873 62,797 62,038 62,837 63,768 63,936 59,107 61,196 63,282 65,398
1,290 1,293 1,267 1,259 1,259 1,261 1,264 1,270 1,269 1,277 1,279 1,283

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?